INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-683 Cr | ₹-327 Cr | ₹-893 Cr | ₹-160 Cr | ₹-24 Cr |
What is the latest Cash Flow from Investing Activities ratio of INDEGENE ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-683 Cr |
Mar2024 | ₹-327 Cr |
Mar2023 | ₹-893 Cr |
Mar2022 | ₹-160 Cr |
Mar2021 | ₹-24 Cr |
How is Cash Flow from Investing Activities of INDEGENE Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-683 Cr | Negative | |
Mar2024 | ₹-327 Cr | Negative | |
Mar2023 | ₹-893 Cr | Negative | |
Mar2022 | ₹-160 Cr | Negative | |
Mar2021 | ₹-24 Cr | - |
Compare Cash Flow from Investing Activities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,807.0 Cr | -1.8% | 0.5% | -10.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,631.0 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
CIPLA | ₹123,419.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -1.8% |
0.5% |
-10.1% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses